Novan Enters Into Agreement To Sell Substantially All Of Its Assets, Including Berdazimer Gel, 10.3%, And Files For Chapter 11 Protection; Announces Commitment From Ligand To Fund $15M In Debtor-In-Posession Financing
– The Company and Ligand Pharmaceuticals sign agreement to sell substantially all of Novan's assets under Section 363 of the U.S. Bankruptcy Code, along with a commitment from Ligand to fund $15 million in debtor-in-possession financing –
